STING & TLR-Targeting Therapies Summit

The STING & TLR-Targeting Therapies Summit covers topics such as:

• Enhancing Administration & Delivery of Therapies for Safe & Effective Clinical Outcomes
• Priming Both the Innate and Adaptive Immunity Pathways
• Progress in Targeting Innate Immunity in Combination Immunotherapies
• Developing an Innate Immune Modulator Capable of Delivering Clinical Responses in Solid Tumors
• Tumor Specific Immunity and Anti-Viral Immunity In Vivo
• Innate Immune Stimulating Antibody Conjugates
• Lifting the Innate Immune Barriers to Prime Anti-Tumor Immunity in Difficult-to-Treat Cancers

The STING & TLR-Targeting Therapies Summit will be held on 25-27 May 2021.